COVID- 19 Vaccination (Coursework Sample)

Presenters Commentary Notes: Slide 1 Introduction: The development of such kinds of vaccines is highly recommended during the ongoing age. It is obvious that diseases and even chronic pandemics do not inform prior to spreading across the globe. Thus, in order to tackle such kinds of severe outbreaks, the development of 3D vaccines has become necessary. The in-vitro method is one which is used to make new kinds of entities while utilizing new scientific technologies for the betterment of mankind within a very less time period. Similarly, the idea of developing 3D- vaccination for COVID-19 has been put forward for the survival of mankind during the pandemic outbreak. Slide 2: Literature Review: The previous work examples that were found in the literature are about the easy and accessible 3D printer in remote areas and third-world countries by speaking about the evaluation of the vaccine process (such as Choi, Ibrahim and Mallakpour) and they do discuss the 3D printer techniques as they are useful for the common people or not. Slide 3: Hypothesis and Objectives: 3D vaccination technique is necessary for the easy distribution of the vaccination across such areas of the world where the provision seems difficult. It would save lives there with the help of a very quick distribution among such individuals without wastage time. It would make quickly prevention of the spread of the disease. Slide 4: Methodology: It was a review study so, the sources that could be authentic for collecting the data were official websites of the organizations, peer review journals, and Google- Scholar contacted and NCBI articles played a role as a helping and supporting platform. Some helpful articles were taken from online random but related websites too. The inclusion criteria were the first 3 pages of Google Scholar and the other criteria were to include only the papers containing the name “3 D Printer and COVID”. Slide 5: Limitations and Future Implications: The main limitations of a research review are researcher bias, gaps in knowledge and translation of the multilingual data into the used language. All these limitations were taken care of as the slides indicate and all may read (the slides may be read here). Turning towards the positive aspects of the provision of 3D printed COVID-19 vaccination; it would make a significant contribution to saving the lives of individuals in such ignored and difficult reachable areas. Moreover, it would also help in avoiding discriminatory behaviour in terms of the provision of healthcare facilities to every individual. Additionally, it would also help I maintain the mental health of people in such stressful situations as the vaccination would give much relief to individuals. Slide 6: Results and Discussion The result and discussion used for this paper were concluded from the given resources or references at the end of the presentation and these results and discussions include that it is least possible to generalize the effects of 3D printer technology among the rich as well as poor people because it’s not that cheap. It’s expensive so far and out of reach of poor people despite of its breathtaking benefits. Anyone may read the slide to know the results. Slide 7: Limitations and Future Implementations: The result and discussion used for this paper were concluded from the given resources or references at the end of the presentation and these results and discussions include that it is least possible to generalize the effects of 3D printer technology among the rich as well as poor people because it’s not that cheap. It’s expensive so far and out of reach of poor people despite of its breathtaking benefits. Anyone may read the slide to know the results. References Aziz, A. B., Raqib, R., Khan, W. A., Rahman, M., Haque, R., Alam, M., ... & Ross, A. G. (2020). Integrated control of COVID-19 in resource-poor countries. International Journal of Infectious Diseases, 101, 98-101. Choi, J. Y., Mahadik, B., & Fisher, J. P. (2021). 3D printing technologies for in vitro vaccine testing platforms and vaccine delivery systems against infectious diseases. Essays in Biochemistry, 65(3), 519-531. Center for Biologics Evaluation and Research. (2020, December 14). Vaccine development – 101. U.S. Food and Drug Administration. Retrieved February 20, 2022, from https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/vaccine-development-101 Christodoulou, M. (2019, February 27). CEPI awards US $ 34 million contract to CureVac to advance the RNA printer™-a mRNA vaccine platform that can rapidly combat multiple diseases. CEPI. Retrieved February 19, 2022, from https://cepi.net/news_cepi/cepi-awards-contract-to-curevac-to-advance-the-rna-printer-a-mrna-vaccine-platform-that-can-rapidly-combat-multiple-diseases/ Gouglas, D., Christodoulou, M., Plotkin, S. A., & Hatchett, R. (2019). Cepi: Driving progress toward epidemic preparedness and response. Epidemiologic Reviews, 41(1), 28–33. https://doi.org/10.1093/epirev/mxz012 Ibrahim, A. M. S., Jose, R. R., Rabie, A. N., Gerstle, T. L., Lee, B. T., & Lin, S. J. (2015, August 10). Three-dimensional printing in developing countries: Plastic and reconstructive surgery – global open. LWW. Retrieved February 18, 2022, fromhttps://journals.lww.com/prsgo/Fulltext/2015/07000/Three_dimensional_Printing_in_Developing_Countries.18.aspx Mallakpour, S., Behranvand, V., & Hussain, C. M. (2022). Worldwide fight against COVID-19 using nanotechnology, polymer science, and 3D printing technology. Polymer Bulletin. https://doi.org/10.1007/s00289-021-04006-z source..